Diagnostics startup ID Genomics will accelerate its development of a quick test for variants of the COVID-19 virus with a new grant from the U.S. National Institutes of Health. The Seattle-based company announced the $300,000 small business grant Tuesday for the dipstick-based test, currently dubbed CovNET. ID Genomics is also eligible for a follow-on grant of up to $3 million.
May 13, 2022
Possible Finance, a Seattle startup that offers loans, just raised an additional $20 million and plans to launch a new credit card. Read the full article here.
May 12, 2022
Seattle is known for being a game development hub. The city has been been the birthplace of popular games such as the original Halo and the wildly popular Pokemon Go....